Daiichi Kigenso Kagaku KogyoDAIICHI KIGENSO KAGAKU KOGYO CO.,LTD.4082東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥10 is left as operating profit. Revenue changed +6.3% from the prior year, operating profit +52.5%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 6.3% | 0.51× | 3.2% | 1.87× | 6.0% |
| 2023 | 11.2% | 0.58× | 6.5% | 1.90× | 12.3% |
| 2024 | 3.2% | 0.54× | 1.7% | 1.90× | 3.3% |
| 2025 | 2.4% | 0.52× | 1.2% | 1.87× | 2.3% |
| 2026 | 7.0% | 0.54× | 3.8% | 1.84× | 7.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 29,366 | 35,748 | 35,220 | 33,641 | 35,751 |
| Cost of revenue | 21,176 | 25,140 | 26,907 | 25,289 | 25,418 |
| Gross profit | 8,189 | 10,607 | 8,313 | 8,352 | 10,333 |
| SG&A | 4,421 | 5,216 | 5,890 | 6,069 | 6,853 |
| Operating income | 3,769 | 5,391 | 2,422 | 2,282 | 3,479 |
| Pretax income | 3,535 | 5,809 | 2,568 | 1,709 | 3,437 |
| Income tax | 1,650 | 1,749 | 1,411 | 900 | 912 |
| Net income attributable to owners | 1,850 | 4,020 | 1,140 | 792 | 2,514 |
| Operating margin | 12.8% | 15.1% | 6.9% | 6.8% | 9.7% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥8.33B | ¥10B | ¥8.29B | ¥8.92B | ¥11.1B |
| Total assets | ¥58B | ¥66B | ¥65.6B | ¥64.8B | ¥66.9B |
| Net assets | ¥31.8B | ¥36.2B | ¥36.3B | ¥38.5B | ¥39B |
| Share capital | ¥787.1M | ¥787M | ¥787M | ¥787M | ¥787M |
| Trade receivables | ¥6.03B | ¥6.62B | ¥6.81B | ¥6.23B | ¥6.63B |
| Property, plant and equipment | ¥24.6B | ¥27.3B | ¥27.7B | ¥26.8B | ¥24.8B |
| Intangible assets excluding goodwill | ¥1.39B | ¥1.28B | ¥1.49B | ¥1.75B | ¥876M |
| Investment securities | ¥737.6M | ¥781M | ¥1.06B | ¥873M | ¥837M |
| Current assets | ¥28.5B | ¥34B | ¥32.5B | ¥31.9B | ¥36.2B |
| Current liabilities | ¥10.1B | ¥10B | ¥9.91B | ¥8.71B | ¥12.1B |
| Trade payables | ¥873.1M | ¥977M | ¥1.47B | ¥1.18B | ¥1.95B |
| Short-term borrowings | ¥2.9B | ¥2.4B | ¥800M | ¥300M | ¥2.2B |
| Long-term borrowings | ¥15.7B | ¥19.2B | ¥18.1B | ¥15.9B | ¥14.1B |
| Total liabilities | ¥26.2B | ¥29.9B | ¥29.3B | ¥26.3B | ¥27.9B |
| Non-controlling interests | ¥620.8M | ¥629M | ¥591M | ¥564M | ¥574M |
| Equity attributable to owners of parent | ¥31B | ¥34.4B | ¥34.9B | ¥34.9B | ¥36.5B |
| Retained earnings | ¥29.1B | ¥32.4B | ¥32.9B | ¥33.1B | ¥34.9B |
| Treasury stock | -¥40.2M | -¥30M | -¥18M | -¥124M | -¥349M |
EDINET (FSA Japan)
有価証券報告書－第70期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第69期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第68期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第67期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第66期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第65期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 54 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.